Sign in

CIK 0001070081

  • Large accelerated filer

PTC THERAPEUTICS, INC.

Sign in to watch
Ticker
PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043416587
Phone
+1 908-222-7000
Business address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
Former names
PTC THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,548,017
in 9 filings, $7.5M under 10b5-1 plans

Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-15 Jacobson Allan Steven Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2024-02-15 ZELDIS JEROME B Director Grant or award +4,000 14,500
2024-02-15 ZELDIS JEROME B Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2024-02-15 Young Alethia Director Grant or award +4,000 13,067
2024-02-15 Young Alethia Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2024-02-15 Reeve Emma Director Grant or award +4,000 11,200
2024-02-15 Reeve Emma Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2024-02-15 STEELE GLENN JR MD PHD Director Grant or award +4,000 14,500
2024-02-15 STEELE GLENN JR MD PHD Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2024-02-15 Smith Mary L. Director Grant or award +4,000 13,813
2024-02-15 Smith Mary L. Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2024-01-30 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sale 10b5-1 −618 $27.25 $17K 61,202
2024-01-30 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sale 10b5-1 −28 $27.25 $763 3,706
2024-01-30 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −794 $27.25 $22K 71,189
2024-01-30 Pauwels Eric CHIEF BUSINESS OFFICER Sale 10b5-1 −366 $27.25 $10K 44,181
2024-01-30 Utter Christine Marie SVP, CHIEF ACCOUNTING OFFICER Sale 10b5-1 −318 $27.25 $9K 35,528
2024-01-22 Jacobson Allan Steven Director Option exercise 10b5-1 +10,000 $27.05 $271K 22,348
2024-01-22 Jacobson Allan Steven Director Sale 10b5-1 −10,000 $27.38 $274K 12,348
2024-01-22 Jacobson Allan Steven Director Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 $27.05 $271K 0
2024-01-09 Utter Christine Marie SVP, FINANCE & CAO Sale 10b5-1 −1,653 $29.01 $48K 35,846

Page 35 of 41 · 804 trades